06.16.15
Adents, a provider of serialization and track-and-trace software solutions for the pharmaceutical and life sciences industries, has opened its first U.S. location in Princeton, NJ. The opening comes just months after Adents, which is headquartered near Paris, France, debuted its first North American subsidiary in Montreal, Canada. By the end of 2015, the company expects to have approximately 50 North American personnel.
In less than a decade—the company was founded in 2007—Adents has made a name for itself in the European serialization sector, where it handles track-and-trace not only for pharmaceuticals but also luxury cosmetics and high-end wine and champagne. For Adents, entrance into the U.S. market is a logical next step for continued growth, particularly in light of the pending, potentially rolling implementation of 2013’s Drug Supply Chain Security Act.
Adents’ serialization software is designed to operate with all existing Enterprise Resource Planning (ERP) and/or MES software systems and devices. This hassle-free line incorporation is a key selling point because, in the continued march toward unit-level serialization, pharmaceutical companies and CMOs are increasingly in the market for efficient, globally applicable track-and-trace solutions capable of meeting immense logistical challenges, such as those pertaining to data exchange and management.
Adents has two primary product portfolios. The company’s suite of solutions for pharmaceutical companies and contract manufacturers (CMOs) identifies and affiliates each individual product unit, and can be modified to suit individual customer production lines. Adents’ pharmaceutical serialization software also is scalable, with flexibilities that help customers meet changing international regulatory requirements. The software also is compatible with a broad range of existing hardware, making it exceedingly easy to implement.
“Adents USA will provide enhanced sales, marketing and support for our expanding U.S. customer base,” said Christophe Devins, chief executive officer, Adents. “We have introduced our products and services to the North American market at a variety of trade shows, and will exhibit at several more in the coming months to help pharmaceutical companies gain a more comprehensive understanding of our unique value proposition.”
As part of the company’s new U.S, presence, Adents will be exhibiting at the 14th annual Contract Pharma Conference, September 18-19 in New Brunswick, NJ, as well as Pack EXPO Las Vegas, September 28-30, 2015.
In less than a decade—the company was founded in 2007—Adents has made a name for itself in the European serialization sector, where it handles track-and-trace not only for pharmaceuticals but also luxury cosmetics and high-end wine and champagne. For Adents, entrance into the U.S. market is a logical next step for continued growth, particularly in light of the pending, potentially rolling implementation of 2013’s Drug Supply Chain Security Act.
Adents’ serialization software is designed to operate with all existing Enterprise Resource Planning (ERP) and/or MES software systems and devices. This hassle-free line incorporation is a key selling point because, in the continued march toward unit-level serialization, pharmaceutical companies and CMOs are increasingly in the market for efficient, globally applicable track-and-trace solutions capable of meeting immense logistical challenges, such as those pertaining to data exchange and management.
Adents has two primary product portfolios. The company’s suite of solutions for pharmaceutical companies and contract manufacturers (CMOs) identifies and affiliates each individual product unit, and can be modified to suit individual customer production lines. Adents’ pharmaceutical serialization software also is scalable, with flexibilities that help customers meet changing international regulatory requirements. The software also is compatible with a broad range of existing hardware, making it exceedingly easy to implement.
“Adents USA will provide enhanced sales, marketing and support for our expanding U.S. customer base,” said Christophe Devins, chief executive officer, Adents. “We have introduced our products and services to the North American market at a variety of trade shows, and will exhibit at several more in the coming months to help pharmaceutical companies gain a more comprehensive understanding of our unique value proposition.”
As part of the company’s new U.S, presence, Adents will be exhibiting at the 14th annual Contract Pharma Conference, September 18-19 in New Brunswick, NJ, as well as Pack EXPO Las Vegas, September 28-30, 2015.
